Beximco Pharma

Source: Wikipedia, the free encyclopedia.
Beximco Pharmaceuticals Ltd
RevenueIncrease 3926.7 crore (US$370 million) (2023)[1]
Increase 691.2 crore (US$64 million) (2023)[1]
Decrease 461.4 crore (US$43 million) (2023)[1]
Number of employees
4,523 (2019)[2]
Websitewww.beximcopharma.com

Beximco Pharmaceuticals Ltd, also known as Beximco Pharma (stylised as BEXIMCO PHARMA) is a Bangladeshi

pharmaceutical company.[3] It is a part of Bangladesh Export Import Company Limited (BEXIMCO).[4]

History

Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of

AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets. It was the first drug company from Bangladesh to sell its products in the US.[6]

In May 2020, the company introduced the world's first generic

Emorivir
.

Factories

Beximco Pharma manufacturing facilities are spread across a 20-acre (81,000 m2) site located in

Dhaka, Bangladesh. The facilities consist of a number of purpose-built plants, including a new Oral Solid Dosage
(OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses. The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others.

Exports

On August, 2007, Beximco exported its

pharmaceutical market ($1.3 billion in 2007), is highly dependent on imported medicines.[10]

References

  1. ^ a b c "Beximco Pharmaceuticals Ltd". WSJ. Retrieved 18 January 2024.
  2. ^ "Beximco Pharma Annual Report 2018-19" (PDF). Retrieved 23 December 2019.
  3. ^ "BD firm plans to export version of Tamiflu". Daily Times. 2006-04-05. Archived from the original on 2011-06-06. Retrieved 2008-03-08.
  4. ^ "Bangladesh forays into US market with Beximco Pharma". bdnews24.com. Retrieved 2016-10-03.
  5. ^ Letter, The Pharma. "Beximco Pharma Q3 revenue up". www.thepharmaletter.com. Retrieved 2016-10-03.
  6. ^ "US FDA approves Beximco Pharma's blood pressure drug". Dhaka Tribune. Archived from the original on 2016-09-30. Retrieved 2016-10-03.
  7. ^ "Beximco introduces remdesivir for Covid-19 treatment". The Daily Star. 2020-05-21. Retrieved 2020-05-24.
  8. ^ "Beximco Pharma introduces world's first generic Remdesivir for COVID-19 treatment". The Financial Express. Dhaka. Retrieved 2020-05-24.
  9. ^ Siddiqui, Zeba (2020-05-05). "Exclusive: Bangladesh's Beximco to begin producing COVID-19 drug remdesivir - COO". Reuters. Retrieved 2021-03-06.
  10. ^ "Bangladesh Beximco exports drugs to Philippines". Reuters. 29 August 2007.

External links